PROM AATD
Research type
Research Study
Full title
Development of a disease specific patient reported outcome in Alpha-1 Antitrypsin deficiency (AATD)
IRAS ID
301816
Contact name
Alice M Turner
Contact email
Sponsor organisation
University of Birmingham
Duration of Study in the UK
1 years, 11 months, 31 days
Research summary
The aim of this study is to develop and produce a patient reported outcome measure (PROM) specifically aimed at patients with alpha-1 antitrypsin deficiency. It is proposed that the PROM will be utilised in both clinical care and also in clinical research trials.
REC name
Wales REC 4
REC reference
22/WA/0028
Date of REC Opinion
19 Jan 2022
REC opinion
Further Information Favourable Opinion